PMC:7029759 / 9801-10064 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"237","span":{"begin":28,"end":37},"obj":"Species"},{"id":"242","span":{"begin":189,"end":205},"obj":"Chemical"},{"id":"249","span":{"begin":71,"end":81},"obj":"CellLine"}],"attributes":[{"id":"A237","pred":"tao:has_database_id","subj":"237","obj":"Tax:2697049"},{"id":"A242","pred":"tao:has_database_id","subj":"242","obj":"MESH:D009841"},{"id":"A249","pred":"tao:has_database_id","subj":"249","obj":"CVCL:U508"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"This RNA genome sequence of 2019-nCoV was recently published (GenBank: MN908947.3), and one strategy that could be considered then, is the use of small interfering RNA (siRNA) or antisense oligonucleotides (ASO) to combat the virus by targeting its RNA genome 23."}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T179","span":{"begin":9,"end":15},"obj":"SO:0001026"},{"id":"T178","span":{"begin":28,"end":37},"obj":"SP_7"},{"id":"T177","span":{"begin":146,"end":167},"obj":"SO:0000646"},{"id":"T176","span":{"begin":169,"end":174},"obj":"SO:0000646"},{"id":"T175","span":{"begin":179,"end":188},"obj":"SO:0000077"},{"id":"T174","span":{"begin":226,"end":231},"obj":"NCBITaxon:10239"},{"id":"T173","span":{"begin":253,"end":259},"obj":"SO:0001026"}],"text":"This RNA genome sequence of 2019-nCoV was recently published (GenBank: MN908947.3), and one strategy that could be considered then, is the use of small interfering RNA (siRNA) or antisense oligonucleotides (ASO) to combat the virus by targeting its RNA genome 23."}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T44","span":{"begin":5,"end":8},"obj":"Body_part"},{"id":"T45","span":{"begin":9,"end":15},"obj":"Body_part"},{"id":"T46","span":{"begin":164,"end":167},"obj":"Body_part"},{"id":"T47","span":{"begin":249,"end":252},"obj":"Body_part"},{"id":"T48","span":{"begin":253,"end":259},"obj":"Body_part"}],"attributes":[{"id":"A44","pred":"fma_id","subj":"T44","obj":"http://purl.org/sig/ont/fma/fma67095"},{"id":"A45","pred":"fma_id","subj":"T45","obj":"http://purl.org/sig/ont/fma/fma84116"},{"id":"A46","pred":"fma_id","subj":"T46","obj":"http://purl.org/sig/ont/fma/fma67095"},{"id":"A47","pred":"fma_id","subj":"T47","obj":"http://purl.org/sig/ont/fma/fma67095"},{"id":"A48","pred":"fma_id","subj":"T48","obj":"http://purl.org/sig/ont/fma/fma84116"}],"text":"This RNA genome sequence of 2019-nCoV was recently published (GenBank: MN908947.3), and one strategy that could be considered then, is the use of small interfering RNA (siRNA) or antisense oligonucleotides (ASO) to combat the virus by targeting its RNA genome 23."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T86","span":{"begin":226,"end":231},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_10239"}],"text":"This RNA genome sequence of 2019-nCoV was recently published (GenBank: MN908947.3), and one strategy that could be considered then, is the use of small interfering RNA (siRNA) or antisense oligonucleotides (ASO) to combat the virus by targeting its RNA genome 23."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T25","span":{"begin":189,"end":205},"obj":"Chemical"}],"attributes":[{"id":"A25","pred":"chebi_id","subj":"T25","obj":"http://purl.obolibrary.org/obo/CHEBI_7754"}],"text":"This RNA genome sequence of 2019-nCoV was recently published (GenBank: MN908947.3), and one strategy that could be considered then, is the use of small interfering RNA (siRNA) or antisense oligonucleotides (ASO) to combat the virus by targeting its RNA genome 23."}

{"project":"LitCovid-sentences","denotations":[{"id":"T60","span":{"begin":0,"end":263},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"This RNA genome sequence of 2019-nCoV was recently published (GenBank: MN908947.3), and one strategy that could be considered then, is the use of small interfering RNA (siRNA) or antisense oligonucleotides (ASO) to combat the virus by targeting its RNA genome 23."}